Amarantus BioSciences, Inc. and Rainbow BioSciences, LLC Announce NuroPro Parkinson's Diagnostic as Target for Joint Venture  
10/8/2012 9:58:37 AM

NOKOMIS, Fla. And SUNNYVALE, Calif.--(BUSINESS WIRE)--Rainbow Coral Corp. (OTCBB: RBCC) biotech subsidiary Rainbow BioSciences and Amarantus Biosciences (OTCBB: AMBS) have moved into the final stages of the terms for a deal. The pending joint venture agreement will see the two entities working together to move the Amarantus NuroPro Parkinson’s diagnostic platform towards commercialization.